Skip to main content

New Products

  • Salix, Progenics ink licensing deal for Relistor

    TARRYTOWN, N.Y. — Salix Pharmaceuticals and Progenics Pharmaceuticals have entered a licensing agreement for a drug used to treat side effects of opioid use.

    The two companies signed the agreement for Relistor (methylnaltrexone bromide), an injected drug used to treat opioid-induced constipation in patients for whom laxatives haven’t worked.

  • Dannon's Activia Parfait Crunch hits store shelves

    WHITE PLAINS, N.Y. — Dannon has expanded its Activia line with a blend of low-fat yogurt, fruit pieces and low-fat crunchy granola.

    New Activia Parfait Crunch contains 220 calories and 3 g of fat per 6-oz. container. Rolling out nationwide this month, Parfait Crunch will be available in strawberry and granola, mixed berry and granola, vanilla and granola, and peach and granola varieties.

    Dannon's Activia yogurt contains a probiotic culture that helps regulate the digestive system, according to the company.

  • Briarpatch to debut five new I Spy games

    MILLBURN, N.J. — Briarpatch is bringing five new riddle-solving I Spy games to the market.

    New to the I Spy lineup are:

    • The two new I Spy Mini games are clip-on games that are perfect for on-the-go kids. The titles in the set are I Spy Mini Shadow Match and I Spy Mini Memory. I Spy Mini-Games are designed for ages 4 years and up, and one or more players;

  • Elite granted FDA approval for generic Adipex-P

    NORTHVALE, N.J. — The Food and Drug Administration has approved a generic weight-loss drug made by Elite Pharmaceuticals.

    Elite announced Friday the approval of phentermine hydrochloride in the 37.5-mg strength, a generic version of Teva’s Adipex-P.

    Branded and generic versions of the drug had sales of around $40 million in 2010, according to Elite.

  • Enbrel helps improve conditions of psoriasis patients, study finds

    THOUSAND OAKS, Calif. — A drug used to treat inflammatory diseases improved the conditions of patients with psoriasis that affected the scalp compared with placebo, according to results of a new study.

    Amgen and Pfizer on Friday announced the results of the phase-4 study of Enbrel (etanercept), in patients with moderate to severe plaque psoriasis with scaling on the scalp, also known as scalp involvement. Data from the trial will be presented Friday at the 69th annual meeting of the American Academy of Dermatology in New Orleans.

  • Coppertone rolls out foaming lotion sunscreens

    WHITEHOUSE STATION, N.J. — Coppertone, which is made by Merck's Consumer Care division, is gearing up for summer with its new foaming lotion sunscreens.

    "Our breakthrough foaming lotion technology offered the opportunity to reinvent our Water Babies and Oil Free products," stated Patricia Agin, fellow in skin care research and development at the Solar Research Center. "We continuously innovate to meet consumers' evolving needs for gentle protection in easy-to-use formulas."

    The new products for 2011 include:

  • Fisk acquires Barielle brand

    NEW YORK — Fisk Industries, a manufacturer of niche-oriented cosmetics and health- and beauty-aid products, has acquired the Barielle line of nail, skin and foot care products.

    Financial terms of the deal were not disclosed.

  • Intimate Bridge 2 Conception developing an OTC take-home insemination device

    PITTSBURGH — A private entrepreneur is close to introducing a take-home intracervical insemination fertilization kit to retail, according to a story published in the Pittsburgh Post-Gazette Friday. The product will be submitted for Food and Drug Administration approval in the first half of 2011. If approved, Steve Bollinger first plans to introduce the product into doctor’s offices before launching through retail pharmacy.

X
This ad will auto-close in 10 seconds